Abstract |
Semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1), is a member of the copper-dependent amine oxidase family that is associated with various forms of inflammation and fibrosis. To investigate the therapeutic potential of SSAO/ VAP-1 inhibition, potent and selective inhibitors with drug-like properties are required. PXS-4681A [(Z)-4-(2-(aminomethyl)-3-fluoroallyloxy) benzenesulfonamide hydrochloride] is a mechanism-based inhibitor of enzyme function with a pharmacokinetic and pharmacodynamic profile that ensures complete, long-lasting inhibition of the enzyme after a single low dose in vivo. PXS-4681A irreversibly inhibits the enzyme with an apparent Ki of 37 nM and a kinact of 0.26 min(-1) with no observed turnover in vitro. It is highly selective for SSAO/ VAP-1 when profiled against related amine oxidases, ion channels, and seven-transmembrane domain receptors, and is superior to previously reported inhibitors. In mouse models of lung inflammation and localized inflammation, dosing of this molecule at 2 mg/kg attenuates neutrophil migration, tumor necrosis factor-α, and interleukin-6 levels. These results demonstrate the drug-like properties of PXS-4681A and its potential use in the treatment of inflammation.
|
Authors | Jonathan S Foot, Tin T Yow, Heidi Schilter, Alberto Buson, Mandar Deodhar, Alison D Findlay, Lily Guo, Ian A McDonald, Craig I Turner, Wenbin Zhou, Wolfgang Jarolimek |
Journal | The Journal of pharmacology and experimental therapeutics
(J Pharmacol Exp Ther)
Vol. 347
Issue 2
Pg. 365-74
(Nov 2013)
ISSN: 1521-0103 [Electronic] United States |
PMID | 23943052
(Publication Type: Journal Article)
|
Chemical References |
- 4-(2-(aminomethyl)-3-fluoroallyloxy)benzenesulfonamide
- Allyl Compounds
- Anti-Inflammatory Agents
- Cell Adhesion Molecules
- Enzyme Inhibitors
- Small Molecule Libraries
- Sulfonamides
- AOC3 protein, human
- Amine Oxidase (Copper-Containing)
|
Topics |
- Adipose Tissue
(drug effects, enzymology)
- Allyl Compounds
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
- Amine Oxidase (Copper-Containing)
(antagonists & inhibitors)
- Animals
- Anti-Inflammatory Agents
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
- Cell Adhesion Molecules
(antagonists & inhibitors)
- Dermatitis
(drug therapy, enzymology, immunology)
- Disease Models, Animal
- Dogs
- Dose-Response Relationship, Drug
- Enzyme Inhibitors
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
- Humans
- In Vitro Techniques
- Mice
- Microsomes
(drug effects, enzymology)
- Models, Biological
- Molecular Structure
- Pneumonia
(drug therapy, enzymology, immunology)
- Rabbits
- Rats
- Small Molecule Libraries
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
- Species Specificity
- Sulfonamides
(chemistry, pharmacokinetics, pharmacology, therapeutic use)
|